I did not finish that yoga class. Instead, I rolled up my mat and fled the studio for the air-conditioned bathroom where I ...

New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Health-care providers and insurance companies can play a key role in educating, empowering, and supporting women in their ...

Midlife women with a metabolic dysfunction-associated steatotic liver disease diagnosis were more likely to report severe or ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

The transition to menopause isn't always easy. Menopause — which usually occurs at around age 50 — officially begins 12 ...

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

also known as hot flashes, caused by breast-cancer treatments. Besides reducing the frequency of the symptoms compared to placebo, it also showed improvements in sleep disturbances and menopause ...